© 2017 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#PrEP

Descoy Tablet held between tow fingers
Major Clinical Trial of Descovy vs. Truvada as PrEP Begins
Ounce of Prevention sign against a blue sky
8 Tips For Taking Truvada as PrEP
PrEP: The Basics

An Interview With Jack Mackenroth

HIV advocate and “Project Runway”’s first openly HIV-positive contestant, Jack Mackenroth talks about stigma, relationships and Scruff.

San Francisco Continues to Lead U.S. in Efforts to End HIV Epidemic

The latest surveillance report shows a steeply declining diagnosis rate—but also racial disparities.

WATCH: Videos and Tweets Recap the #2017USCA Experience

See a “POZ on Location” video with highlights from the United States Conference on AIDS and scroll through 15 tweets from HIV advocates.

Is It Ethical to Take People Off HIV Meds for Cure Research?

Cure studies typically require a temporary break in HIV treatment, often with little promise of a personal benefit to the participant.

CVS Mailings Reveal HIV Info of 4,000 ADAP Clients

Notations such as “PM 6402 HIV” were visible in CVS Caremark envelopes.

Women Must Be More Adherent to PrEP Than Gay and Bi Men

Truvada metabolizes differently in the vagina than in the rectum, leaving less room for error in protecting vaginal tissues from HIV.

Selzentry as PrEP Is Safe and Well Tolerated Among Women

This alternative to Truvada for prevention among those at high risk of HIV warrants more advanced research to determine its efficacy.
Thinkstock

HIV Diagnoses Continue to Plummet at Major London Sexual Health Clinic

A push to diagnose and rapidly treat HIV and other STIs as well as use of Truvada as PrEP are likely driving the trend.

Did HIV Pharma “Pay to Delay” Generic Truvada?

AIDS activists urge the N.Y. attorney general to investigate possible antitrust violations regarding the HIV med used as PrEP.

Australian State Sees Record Low HIV Diagnosis Rate

New South Wales, which includes Sydney, is likely seeing the benefits of new HIV prevention efforts.

$900K Grant to Expand HIV Services at Planned Parenthood

The Gilead Sciences funding will be carried out in partnership with the Black AIDS Institute.

Hot topics

Treatment-as-Prevention (TasP)
Safer Sex
#Prevention
#Condoms
French AIDS ambassador Michèle Boccoz, executive director of UNAIDS Michel Sidibé, mayor of Paris Anne Hidalgo and Christine Kafando, a community health worker from Burkina Faso, speak at a press conference on the new 90-90-90 UNAIDS report.

International HIV Conference Reveals Exciting Progress in Global HIV Fight

Highlights from the research presented at the 9th International AIDS Society Conference on HIV Science in Paris.

5,000 Cumulative Years of PrEP Use and No HIV Infections

Not satisfied with its success, health care group Kaiser Permanente looks to address those who stop or only consider PrEP and contract HIV.

An Estimated 136,000 People Are on PrEP in the U.S.

PrEP use remains largely limited to white men 25 and older, meaning groups at the very highest risk of HIV are likely not benefiting.

In Austin, It Can Take 2 to 3 Months to Get PrEP

That’s about to change as two more nonprofit clinics open and provide the HIV prevention pill free of charge.
Thinkstock

Gonorrhea Diagnoses Fall as PrEP Use Soars at Key London Clinic

Following a recent finding of a major drop in HIV diagnoses at the 56 Dean St. clinic, the decline in gonorrhea diagnoses is encouraging.
Advertisement